Related Experiment Video
Updated: Jun 3, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Pharmacological adherence to oral anticoagulant and factors that influence the international normalized ratio
Christiane Wahast Avila1, Graziella Badin Aliti, Maria Karolina Ferreira Feijó
1Hospital de Clínicas de Porto Alegre, Escola de Enfermagem, Universidade Federal do Rio Grande do Sul, RS, Brazil. chriswavila@yahoo.com.br
Insights
Shorter anticoagulation time and lower drug costs were linked to better treatment adherence and stable international normalized ratio (INR) levels in patients. Most patients demonstrated high or medium adherence to anticoagulation therapy.
Area of Science:
- Pharmacology
- Clinical Medicine
- Health Economics
Background:
- Anticoagulation therapy requires careful monitoring of blood clotting using the international normalized ratio (INR).
- Patient adherence and factors influencing anticoagulation stability are crucial for effective treatment outcomes.
- Understanding these factors can optimize therapeutic management and improve patient compliance.
Purpose of the Study:
- To investigate the relationship between international normalized ratio (INR) stability and various patient-related factors.
- To identify key determinants of anticoagulation stability and treatment adherence.
- To explore the impact of anticoagulation duration and medication cost on INR stability.
Main Methods:
- A cross-sectional study involving 156 patients undergoing anticoagulation therapy.
- Data collected on INR levels, treatment adherence, age, education, socioeconomic status, drug interactions, comorbidities, vitamin K intake, anticoagulation duration, and drug cost.
- Statistical analysis to correlate INR stability with identified factors.
Main Results:
- Most patients (over 90%) exhibited high or medium adherence to anticoagulation treatment.
- INR stability was positively associated with shorter anticoagulation times and lower drug costs.
- Patients with shorter anticoagulation durations and lower medication expenses demonstrated greater INR stability and adherence.
Conclusions:
- Anticoagulation time and drug cost are significant factors associated with anticoagulation stability.
- High and medium adherence levels are prevalent among patients on anticoagulation therapy.
- Optimizing treatment duration and considering drug affordability may enhance INR stability and patient adherence.
Abstract:
Cross-sectional study developed to relate the international normalized ratio (INR), used as a parameter to monitor the levels of blood clotting, stability to adherence, age, level of education, socioeconomic level, interaction with other drugs, comorbidities, vitamin K intake, anticoagulation time and drug cost. 156 patients were included, mean age 57 ± 13 years, (53.8%) male, 61 (39.1%) had high adherence, 91 (58.3%) medium and 4 (2.6%) low adherence to treatment, 117 (75%) had INR stability up to 50% and 39 (25%) > 75%, patients with shorter time of anticoagulation presented higher stability, those who spent less on the drug remained more stable and had better adherence. It was concluded that more than 90% of patients had high and medium adherence and that the anticoagulation time and drug cost were the factors related to the anticoagulation stability.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Dosage Regimen: Multiple Oral Dosage
Therapeutic Drug Monitoring: Affecting Factors
Dosage Regimen: Individualization
